Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 12, 2006, Pages 1889-1893

  Barbieri, Anna ^a   Sabatini, Laura ^b   Indiveri, Paolo ^b   Bonfiglioli, Roberta ^b   Lodi, Vittorio ^b   Violante, Francesco S ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; PHASE SEPARATION;

ANTINEOPLASTIC DRUGS; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; EXTRACTION LIQUID; HUMAN URINE; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MICRO-LIQUID CHROMATOGRAPHY; SIMULTANEOUS DETERMINATIONS; SOLID-PHASE EXTRACTION;

MASS SPECTROMETRY;

EID: 33745180896     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2527     Document Type: Article

References (17)

1. Valagussa P, Tancini G, Bonadonna G. J. Clin. Oncol. 1987; 5: 1138.
2. Sanderson BJS, Johnson KJ, Henner WD. Mutagenesis 2001; 16: 197. DOI: 10.1093/mutage/16.3.197.
3. Levin LI, Holly EA, Seward JP. J. Natl. Cancer Inst. 1993; 85: 1089.
4. Gabriele P, Airoldi M, Succo G, Barando V, Ruo Redda MG. Oral Oncol. Eur. J. Cancer 1993; 29B: 153. DOI: 10.1016/0964-1955(93)90041-C.
5. Valanis B, Vollmer WM, Steele P. J. Occup. Environ. Med. 1999; 41: 632.
6. OSHA, Technical Manual, Hospital Investigation: Health Hazard, Section VI, 2000.
7. DHHS, NIOSH, Antineoplastic agents Occupational Hazards in Hospitals, Publication No 102, 2004.
8. Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D. Int. Arch. Occup. Environ. Health 2003; 76: 5.
9. Schreiber C, Radon K, Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D. Int. Arch. Occup. Environ. Health 2003; 76: 11.
10. Sabatini L, Barbieri A, Tosi M, Violante FS. J. Mass Spectrom. 2005; 40: 669. DOI: 10.1002/jms.840.
11. Turci R, Fiorentino ML, Sottani C, Minoia C. Rapid Commun. Mass Spectrom. 2000; 14: 173. DOI: 10.1002/(SICI)1097-0231(20000215)14:3〈173::AID- RCM862〉3.0.CO;2-K.
12. Turci R, Sottani C, Ronchi A, Minoia C. Toxicol. Lett. 2002; 134: 57.
13. de Jonge ME, van Dam SM, Hillebrand MJ, Rosing H, Huitema AD, Rodenhuis S, Beijnen JH. J. Mass Spectrom. 2004; 39: 262. DOI: 10.1002/jms.570.
14. International Agency for Research on Cancer (IARC). Monogr. Eval. Carcinog. Risks Hum. 2000; vol.76.
15. Kasel D, Jetter A, Harlfinger S, Gebhardt W, Fuhr U. Rapid Commun. Mass Spectrom. 2004; 18: 1472. DOI: 10.1002/ rcm.1508.
16. Sottani C, Tranfo G, Faranda P, Minoia C. Rapid Commun. Mass Spectrom. 2005; 19: 2794. DOI: 10.1002/rcm.2116.
17. US Food and Drug Administration Center for Drug Evaluation and Research, Guidance for Industry, Bioanalytical Method Validation. 2001. Available: http://www.fda.gov/ cder/guidance/4252fnl.pdf.